Imaging and Genomic Biomarkers to Predict Response in Prostate Cancer
Status:
Not yet recruiting
Trial end date:
2027-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the imaging and gene expression biomarkers in
prostate cancer. Participants have high-risk prostate cancer and have indicated they will
undergo external beam radiation therapy, brachytherapy, and androgen deprivation therapy
(EBRT+BTX+ADT). Participants can expect to be in this study for up to 5 years.